Status:
COMPLETED
Intraprostatic Injection of Botulinum Toxin A Versus Ethanol for Treatment of Patients With Benign Prostatic Hyperplasia
Lead Sponsor:
Cairo University
Conditions:
Male
Ultrasonography
Eligibility:
MALE
50-75 years
Phase:
NA
Brief Summary
To compare safely and efficacy of intraprostatic injection of botulinum toxin A versus ethanol for treatment of benign prostatic hyperplasia (BPH).
Detailed Description
To compare safely and efficacy of transrectal intraprostatic injection of botulinum toxin A versus ethanol for treatment of symptomatic benign prostatic hyperplasia (BPH) refractory to medical treatme...
Eligibility Criteria
Inclusion
- international prostate symptoms score (IPSS) \> 7
- Qmax \< 15
- Patients with refractory symptomatic BPH to medications
- patients high risk for surgery or unwilling to do surgery
Exclusion
- bladder stones
- acute or chronic urinary retention
- urethral stricture
- bladder or prostatic carcinoma.
- Neurogenic bladder dysfunctions
Key Trial Info
Start Date :
December 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2017
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT03385161
Start Date
December 1 2013
End Date
June 1 2017
Last Update
December 28 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cairo University Hospitals
Cairo, Egypt, 12222